[Definitive radiotherapy versus radiochemotherapy with weekly docetaxel in patients with head and neck cancer and cisplatin intolerance]

Strahlenther Onkol. 2023 Sep;199(9):869-870. doi: 10.1007/s00066-023-02113-6. Epub 2023 Jun 26.
[Article in German]
No abstract available

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Chemoradiotherapy / adverse effects
  • Cisplatin* / adverse effects
  • Docetaxel
  • Head and Neck Neoplasms* / therapy
  • Humans

Substances

  • Docetaxel
  • Cisplatin